Li Xu-Hui, Wang Elaine Lu, Zhou Hai-Meng, Yoshimoto Katsuhiko, Qian Zhi Rong
Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China ; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang 314006, China.
Department of Legal Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan ; Department of Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503, Japan.
Int J Endocrinol. 2014;2014:435171. doi: 10.1155/2014/435171. Epub 2014 Dec 8.
MicroRNAs (miRNAs) are a class of recently identified noncoding RNAs that regulate gene expression at posttranscriptional level. Due to the large number of genes regulated by miRNAs, miRNAs play important roles in many cellular processes. Emerging evidence indicates that miRNAs are dysregulated in pituitary adenomas, a class of intracranial neoplasms which account for 10-15% of diagnosed brain tumors. Deregulated miRNAs and their targets contribute to pituitary adenomas progression and are associated with cell cycle control, apoptosis, invasion, and pharmacological treatment of pituitary adenomas. To provide an overview of miRNAs dysregulation and functions of these miRNAs in pituitary adenoma progression, we summarize the deregulated miRNAs and their targets to shed more light on their potential as therapeutic targets and novel biomarkers.
微小RNA(miRNA)是一类最近发现的非编码RNA,它们在转录后水平调节基因表达。由于受miRNA调控的基因数量众多,miRNA在许多细胞过程中发挥着重要作用。新出现的证据表明,在垂体腺瘤(一种占诊断出的脑肿瘤10%-15%的颅内肿瘤)中miRNA表达失调。失调的miRNA及其靶标促进垂体腺瘤进展,并与垂体腺瘤的细胞周期控制、凋亡、侵袭及药物治疗相关。为了概述miRNA失调情况以及这些miRNA在垂体腺瘤进展中的功能,我们总结了失调的miRNA及其靶标,以更深入了解它们作为治疗靶点和新型生物标志物的潜力。